References
CAPRIE Steering Committee: A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE): Lancet 1996, 348:1329–1339.
The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-T segment elevation. N Engl J Med 2001, 345:494–502.
Mohr JP, Thompson JLP, Lazar RM, et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001, 345:1444–1451.
Hass WK, Easton JD, Adams HP Jr, et al.: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1988, 321:501–507.
Gorelick PB, Richardson DJ, Kelly M, et al., for the African American Antiplatelet Stroke Prevention Study (AAASPS) Investigators: Aspirin and ticlopidine for prevention of recurrent stroke in black patients. A randomized trial. JAMA 2003, 2947–2957.
European Stroke Prevention Study 2: Efficacy and safety data. J Neurol Sci 1997, 151:S1-S77.
Rights and permissions
About this article
Cite this article
Weinberger, J. Clinical trials report. Curr Cardiol Rep 7, 7–9 (2005). https://doi.org/10.1007/s11886-005-0003-9
Issue Date:
DOI: https://doi.org/10.1007/s11886-005-0003-9